CD8A and breast carcinoma: DRibbles induce efficient cross-presentation, activate naïve CD8+ T cells in vivo and in vitro, and induce cross-protective and therapeutic antitumor immune responses against multiple, antigen distinctive, sarcomas [11] and mammary carcinomas (Twitty C et all manuscript in preparation, Li Y et al manuscript in preparation).